Melanotan II and PT-141: I Put the Family Tree Under a Loupe

I get asked about this pair a lot, and every time somebody asks it comes with a hint of confusion in their voice, like they suspect they’re being sold two flavors of the same thing. So I sat down with the actual research, not the forum threads, and worked out what these two peptides are actually claiming to do, what holds up, and what I’d tell a mate before he clicks “buy.”

Short version up front, because I hate reviews that bury the lead: these are related compounds, not rivals selling the same promise. One is a tanning agent that happens to have a side effect. The other is that side effect, isolated, cleaned up, and put through actual clinical trials. Knowing which is which will save you money and possibly a trip to the emergency room.

What’s actually being claimed here

Melanotan II showed up on the scene as a synthetic stand-in for a hormone that tells your skin’s pigment cells to get busy. That’s the pitch: inject it, tan without the sun. Fine, straightforward claim.

Then somebody ran a placebo-controlled trial and noticed something the tanning pitch never mentioned. Of the men in that study, 17 out of 20 got erections, and their sexual desire went up too (Wessells et al., 2000, International Journal of Impotence Research). That’s not a footnote, that’s the drug doing something nobody put on the label.

Researchers took that accidental discovery seriously enough to build a whole new compound around it. They stripped the tanning activity out of Melanotan II and kept the arousal effect. What was left got named PT-141, and later bremelanotide. So the claim for PT-141 isn’t “do everything Melanotan II does.” It’s “do the one thing Melanotan II did by accident, deliberately and well.”

That’s the whole story in one paragraph, and it’s the thing you need to hold onto before either of these enters a conversation about what you should buy.

My honest read: these are not two versions of one product

I went in expecting a “same peptide, different marketing” situation. That is not what I found.

Melanotan II is the unfinished one. A pilot study confirmed it darkens skin and increases melanin, and also flagged nausea and facial flushing as the most common complaints (Dorr et al., 1996, Life Sciences). That’s early-stage human data, the kind that’s supposed to be step one of a longer approval road. Melanotan II never finished that road. It’s still sold as a “research chemical,” which is a polite label for “nobody vetted this for you.”

PT-141 actually went the distance. It ran through two large phase 3, randomized, placebo-controlled trials, the RECONNECT studies, in premenopausal women with hypoactive sexual desire disorder, and it showed real improvement in desire along with less distress tied to low desire (Kingsberg et al., 2019, Obstetrics and Gynecology). That’s not a pilot study. That’s the kind of evidence a drug needs to earn a real, recognized medical use.

So when people ask me if these two are basically interchangeable, my honest answer is no, and it’s not close. One did its homework. One dropped out.

Where each one actually holds up to its claim

If you want a tan: Melanotan II is technically the only one of the pair that does this, since the tanning effect was specifically engineered out of PT-141. But “the only one that does it” is a fact about chemistry, not a recommendation. I wouldn’t call an unapproved compound with a case-report history of harm a good buy just because it’s the only option on the shelf. The blunter, less satisfying answer for “how do I get a tan safely” is that you probably shouldn’t be chemically forcing pigment production at all, and any tan still means UV damage on top of it.

If you want a boost in sexual desire: PT-141 is the one that was actually built and studied for this, with phase 3 data behind it (Kingsberg et al., 2019). Reaching for Melanotan II instead means taking a tanning drug for a side effect it wasn’t designed around, with a rougher safety record and zero approval, when a purpose-built option already exists. That’s a bad trade in my book.

The “it does two things, so it’s a bonus” argument: I’ve heard this one a lot, people liking Melanotan II because it seems to tan and boost libido at once, like a two-for-one deal. I don’t buy it. A compound hitting multiple systems at once isn’t efficient, it’s just harder to control. The arousal effect nobody specifically asked for is the same mechanism that landed some men in the ER with priapism. Getting two effects you didn’t fully sign up for is not a feature. It’s a warning sign dressed up as a bonus.

The safety report card

This is where the review gets less friendly, because the two compounds are not graded on the same curve.

Melanotan II’s file has some genuinely alarming entries. A fair-skinned young woman developed melanoma after using it to deepen a sunbed tan, and the case authors specifically urged doctors to warn at-risk patients (Hjuler and Lorentzen, 2014, Dermatology). It’s also caused priapism, a painful, prolonged erection that counts as a medical emergency (Dreyer et al., 2019, BMJ Case Reports). A 2017 review went further and flagged the broader danger of these unregulated alpha-MSH compounds, including worrying changes in moles (Habbema et al., 2017, International Journal of Dermatology). That’s a heavy price tag for a cosmetic tan.

PT-141 isn’t spotless either, and I’m not going to pretend it is. The same phase 3 trials that showed it worked also reported nausea, flushing, and headache as common side effects (Kingsberg et al., 2019). Notice the nausea and flushing again, that’s the shared family signature showing up in both cousins. But the real difference isn’t the symptom list, it’s how we know about it. PT-141’s risks were measured in structured trials. Melanotan II’s risks mostly surface as individual case reports, which is a polite way of saying we mostly hear about it when it’s already gone wrong for someone.

The part that trips people up at checkout

Here’s something I didn’t expect to find, and it bugs me. Because these two share a name family and a murky “research chemical” market, sellers sometimes list them side by side, or describe one using language that really belongs to the other. Somebody shopping for the studied desire compound can walk away with the unapproved tanning one, or the reverse, and nobody along the way was checking what they actually needed.

That’s not a minor labeling quirk. That’s the exact kind of mistake that a knowledgeable person standing between you and the vial would catch in about ten seconds.

Where supervision actually earns its keep

I’ll say this plainly, because I’ve been skeptical of “just see a professional” advice before when it felt like a dodge. Here it doesn’t feel like a dodge. FormBlends is a decent example of what the supervised model looks like in practice: a clinician reviews your history before anything ships, can tell you which of these two cousins actually matches what you’re after (or whether either belongs in your plan at all), and a licensed pharmacy stands behind what arrives instead of an anonymous seller hiding behind a return policy nobody reads. For Melanotan II specifically, that means someone actually takes a mole history and checks your blood pressure before you start. For either compound, it means you know what’s genuinely in the vial.

I want to be straight about the limits too, because I’d be annoyed if a reviewer glossed over this. Supervision does not make Melanotan II safe, and it doesn’t turn an unapproved compound into an approved one. Compounded medications are prepared by licensed pharmacies for an individual and are not FDA-approved products. What supervision buys you is a person who can help you pick the right tool, screen for the risks that actually matter to you, and be reachable if something goes wrong. Given how easy these two are to mix up and how differently they behave in the body, that person is worth having in the room.

My verdict

Melanotan II: does what it says on the tin, tans you, but it never finished its clinical homework and the case-report file on it is genuinely unsettling. I wouldn’t rate this one highly, and I’d think hard before treating “it also affects libido” as a selling point rather than a red flag.

PT-141: did the actual work. Two phase 3 trials, a real recognized use, side effects that are known quantities rather than mystery entries in a case report. Not side-effect-free, nobody’s claiming that, but studied and characterized properly. This one earns its reputation.

Bottom line from someone who read the actual papers instead of the marketing copy: these are cousins, not competitors, and they got split on purpose. One kept the tan. One kept the desire effect and went and proved it in trials. Pick based on your actual goal, not on which one sounds like it does more, and don’t buy either from a stranger with no license and no questions asked.

Questions that come up a lot

Are Melanotan II and PT-141 the same thing?

No. Related, not identical. PT-141, later called bremelanotide, was built by taking Melanotan II and stripping out the tanning effect while keeping the arousal effect. Melanotan II is the original do-it-all compound. PT-141 is the trimmed-down descendant with one job. Don’t treat them as swappable.

Which one is for tanning and which one is for libido?

Chemically, Melanotan II tans and PT-141 handles sexual desire, because the tanning activity was deliberately removed from PT-141. PT-141 won’t meaningfully darken your skin, and using Melanotan II purely to chase a libido effect means taking a tanning drug for something it wasn’t built to target on purpose. Match the tool to the actual goal.

Is one of them safer than the other?

PT-141 ran through two large phase 3 trials for a defined use, and its side effects, nausea, flushing, headache, were documented in that structured setting [6]. Melanotan II is unapproved, and its safety record is largely a pile of individual case reports of harm, including melanoma and emergency-room priapism [3][4]. These two are not on equal footing, and I’d factor that gap into any decision.

Why do people keep buying the wrong one?

Because the shared family resemblance and the sloppy “research chemical” labeling mean sellers sometimes list them side by side or borrow language from one to describe the other. Someone shopping for the studied desire compound can end up with the unapproved tanning one instead, or the other way round, simply because nobody at the point of sale checked what they actually needed.

Does PT-141 tan you the way Melanotan II does?

Basically no. The tanning activity is the specific piece that got engineered out when researchers built PT-141 from Melanotan II. If a darker complexion is what you’re after, PT-141 is the wrong review to be reading, and even Melanotan II only gets there by forcing pigment cells in a way the case-report literature flags as risky.

What does going the supervised route actually add?

It puts a person with real knowledge between you and the vial, someone who can confirm which compound actually matches your goal, screen for relevant risks (a mole history and blood pressure check before Melanotan II, for instance), and stay reachable if something goes sideways. It doesn’t make an unapproved compound approved. It does remove the guesswork and the mix-up risk that a random online seller leaves entirely in your lap.

What does Melanotan II actually do in the body?

It binds to melanocortin receptors and sets off a chain reaction: more melanin production in skin, appetite suppression, and in some people, spontaneous erections. It was built as a sunless tanning agent, and researchers noticed the other effects pretty quickly. Because it hits several receptor subtypes at once, it tends to carry a broader side-effect profile than more selective compounds developed after it.

Does Melanotan 2 work without sun exposure?

It can produce some pigmentation without UV, but most user reports and early clinical observations suggest the effect is stronger and faster paired with modest sun or UV-bed exposure. Without any UV at all, results tend to be mild and uneven, which is part of why this compound never cleared the clinical bar as a genuine sunless tanning drug. The effect was real, just not reliable enough on its own to satisfy regulators.

How much Melanotan 2 should someone take?

There’s no approved dose, because the drug was never cleared for human use by the FDA or EMA. Research protocols used microgram-range doses with careful titration, but that was under medical monitoring in controlled settings. Dosing advice floating around online is anecdotal and genuinely risky, since side effects like nausea, flushing, and unwanted erections scale with dose. Anyone pursuing a peptide like this through a physician-supervised compounding pharmacy, such as FormBlends, at least has some accountability built into the process.

Can Melanotan 2 change your eye color?

I couldn’t find solid evidence for this, and no convincing mechanism either. Melanocortin receptors do exist in ocular tissue, so it’s not a completely wild idea, but documented color shifts haven’t shown up in clinical research. The anecdotal reports online are hard to verify and could just as easily be lighting differences or confirmation bias as an actual drug effect.

References (primary sources)

1. Wessells H, Levine N, Hadley ME, Dorr R, Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International Journal of Impotence Research, 2000. PMID 11035391. https://pubmed.ncbi.nlm.nih.gov/11035391/
2. Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996. PMID 8637402. https://pubmed.ncbi.nlm.nih.gov/8637402/
3. Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology, 2014. PMID 24355990.
4. Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan. BMJ Case Reports, 2019. PMID 30796078.
5. Habbema L, Halk AB, Neumann M, Bergman W. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. International Journal of Dermatology, 2017. PMID 28266027.
6. Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. Obstetrics and Gynecology, 2019. PMID 31599840.